Tag

The Khiron sponsored study found 9 out of 10 patients reported some degree of improvement of their chronic pain.

Medical marijuana derivatives are included in the expansive resolution for the first time, though some private insurers had already included cannabis trreatments.

Q3 2021 revenue increased 83% YoY to $3.5 million compared to the previous year. Continued strong gross margins for medical cannabis segment at 89%

The medical cannabis treatment study shows positive results in more than 80% of participants with only minor side-effects.